Pantorex (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantorex, is a proton pump inhibitor presented as an oral tablet for oral use. It belongs to the ATC class A02BC01 and works by inhibiting gastric H+/K+ ATPase, thereby reducing gastric acid secretion. The medication is indicated for the management of gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome.

GNH USA supplies Pantorex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by reducing acid exposure. - Erosive esophagitis: promotes healing of damaged esophageal lining through acid suppression. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence by maintaining low gastric acidity. - Helicobacter pylori eradication: used as part of combination therapy to improve eradication rates. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with possible colitis. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe renal impairment. - Monitor magnesium: prolonged therapy can lead to hypomagnesemia; periodic testing is advised. - Evaluate bone health: long‑term use may increase fracture risk, especially in older patients. - Review concomitant medications: potential interactions with drugs requiring acidic pH for absorption. - Use caution in pregnancy: benefits should outweigh potential risks; consult obstetric guidance. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to increased gastric pH; avoid concurrent use. - Atazanavir: decreased plasma concentrations; avoid or adjust therapy. - Warfarin: enhanced anticoagulant effect; monitor INR closely.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels; monitor for toxicity. - Methotrexate: reduced renal clearance; consider dose reduction. - Clopidogrel: possible reduced antiplatelet activity; assess clinical response.